World's Best Scientists 2026 revealed!
Roel Goldschmeding

Roel Goldschmeding

D-Index & Metrics

Medicine

D-Index
86
Citations
21118
World Ranking
14307
National Ranking
547

Roel Goldschmeding publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roel Goldschmeding sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 319 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roel Goldschmeding D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roel Goldschmeding sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roel Goldschmeding is affiliated with Utrecht University in the Netherlands and has an extensive publication record in the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on nephrology and related molecular mechanisms, evident in the variety and depth of studies published over recent years.

Goldschmeding's work spans key subfields including molecular biology, nephrology, pathology and forensic medicine, pulmonary and respiratory medicine, and immunology. This interdisciplinary approach supports investigations across a spectrum of biological and medical sciences with a special emphasis on kidney-related diseases and systemic conditions.

Notable recent publications by Roel Goldschmeding include:

  • Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities (2021, Clinical Science)
  • Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis (2021, Clinical Science)
  • Genetics-first approach improves diagnostics of ESKD patients <50 years old (2020, Nephrology Dialysis Transplantation)
  • Oxidative Stress and Cellular Senescence Are Involved in the Aging Kidney (2022, Antioxidants)
  • PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-β1-receptor signaling (2021, The FASEB Journal)

Frequent co-authors collaborating with Goldschmeding include:

  • Tri Q. Nguyen (26 joint works)
  • Roel Broekhuizen (17 joint works)
  • Marta Ruíz-Ortega (15 joint works)
  • Floris A. Valentijn (13 joint works)
  • Raúl R. Rodrigues-Díez (12 joint works)

Goldschmeding's research appears prominently in several scientific venues, with multiple publications in:

  • Journal of the American Society of Nephrology (8 publications)
  • Nephrology Dialysis Transplantation (4 publications)
  • Antioxidants (3 publications)
  • Clinical Science (2 publications)
  • Frontiers in Pharmacology (2 publications)

The main focus areas of Goldschmeding's scientific work can be grouped into significant topics such as:

  • Connective Tissue Growth Factor Research
  • Chronic Kidney Disease and Diabetes
  • Systemic Sclerosis and Related Diseases
  • Biomarkers in Disease Mechanisms
  • Renal and related cancers
  • Telomeres, Telomerase, and Senescence
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

This profile outlines Goldschmeding's active and broad research involvement with a clear focus on kidney disease mechanisms, fibrosis, aging, and related cellular signaling pathways, contributing extensively to the nephrology and molecular biology communities through collaboration and publication.

Best Publications

  • Expression of connective tissue growth factor in human renal fibrosis

    Yasuhiko Ito;Jan Aten;Richard J. Bende;Barry S. Oemar

  • Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1

    Jeroen Roose;Gerwin Huls;Moniek van Beest;Petra Moerer

  • Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?

    Ingrid E Blom;Roel Goldschmeding;Andrew Leask

  • Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

    R. Goldschmeding;C. E. Van Der Schoot;D. Ten Bokkel Huinink;C. E. Hack

  • Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

    K.M. Dolman;A.E.G.Kr. von dem Borne;R. Goldschmeding;R.D.B. Gans

  • What is orbital pseudotumor

    Ilse Mombaerts;Roel Goldschmeding;Reinier O. Schlingemann;Leo Koornneef

  • CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC

    Youjun Chen;Ingrid E. Blom;Ingrid E. Blom;Susan Sa;Susan Sa;Roel Goldschmeding;Roel Goldschmeding

  • Proposal for a unified CCN nomenclature

    D. R. Brigstock;R. Goldschmeding;K. I. Katsube;S. C.T. Lam

  • Diverse origins of the myofibroblast—implications for kidney fibrosis.

    Lucas L. Falke;Shima Gholizadeh;Roel Goldschmeding;Robbert J. Kok

  • Connective tissue growth factor (CTGF) from basics to clinics

    Yasaman Ramazani;Noël Knops;Mohamed A. Elmonem;Tri Q. Nguyen

  • ASSOCIATION OF AUTOANTIBODIES TO MYELOPEROXIDASE WITH DIFFERENT FORMS OF VASCULITIS

    J. W. Cohen Tervaert;R. Goldschmeding;J. D. Elema;P. C. Limburg

  • The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.

    Esther J. Kuiper;Frans A. Van Nieuwenhoven;Marc D. de Smet;Jan C. van Meurs

  • FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair

    Weibin Zhou;Edgar A Otto;Andrew Cluckey;Rannar Airik

  • Autoantibodies against myeloid lysosomal-enzymes in crescentic glomerulonephritis

    J. W. Cohen Tervaert;R. Goldschmeding;J.D. Elema;M. van der Giessen

  • Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis

    Maarten B. Rookmaaker;Anke M. Smits;Herman Tolboom;Karin Van 't Wout

  • Are systemic corticosteroids useful in the management of orbital pseudotumors

    Ilse Mombaerts;Reinier O. Schlingemann;Roel Goldschmeding;Leo Koornneef

  • Determination of Human Platelet Antigen Frequencies in the Dutch Population by Immunophenotyping and DNA (allele-specific restriction enzyme) Analysis

    S. Simsek;N. M. Faber;P. M. Bleeker;A. B. J. Vlekke

  • Connective tissue growth factor and cardiac fibrosis.

    A Daniels;M van Bilsen;R Goldschmeding;G J van der Vusse

  • Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease

    Helena M. Kok;Lucas L. Falke;Roel Goldschmeding;Tri Q. Nguyen

  • Kinetics of Connective Tissue Growth Factor Expression during Experimental Proliferative Glomerulonephritis

    Yasuhiko Ito;Roel Goldschmeding;Richard J. Bende;Nike Claessen

Frequent Co-Authors

A. E. G. K. Von Dem Borne
A. E. G. K. Von Dem Borne University of Amsterdam
Karen M. Lyons
Karen M. Lyons University of California, Los Angeles
Pieter A. Doevendans
Pieter A. Doevendans Utrecht University
Ton J. Rabelink
Ton J. Rabelink Leiden University Medical Center
Paul J. Higgins
Paul J. Higgins Albany Medical Center Hospital
Cornelis J.F. Van Noorden
Cornelis J.F. Van Noorden University of Amsterdam
Enrique Brandan
Enrique Brandan San Sebastián University
Jan A. Bruijn
Jan A. Bruijn Leiden University Medical Center
Lise Tarnow
Lise Tarnow Steno Diabetes Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options related to medicine in the USA? There are a variety of online degrees and certifications that can help you build a meaningful career in healthcare. For those interested in health data and records management, rhit programs online offer a convenient way to earn qualifications in health information management.

If working behind the scenes handling patient billing appeals to you, getting a medical coding certification can open doors to many job opportunities. Individuals interested in advanced nursing roles might consider enrolling in the cheapest fnp programs online to become a Family Nurse Practitioner.

For those seeking a more general pathway into nursing, pursuing a nursing degree online can be a cost-effective and flexible way to start a fulfilling healthcare career. Each of these online programs provides unique entry points into healthcare, designed to suit your educational needs, schedule, and career ambitions.

Best Scientists Citing Roel Goldschmeding

Trending Scientists

Recently Published Articles